CNVVF - Convatec Group Plc
| Previous Close | 2.5500 |
| Open | 2.5500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 2.5500 - 2.5500 |
| 52 Week Range | 1.5500 - 2.5500 |
| Volume | 940,928 |
| Avg. Volume | 0 |
| Market Cap | 5.17B |
| Beta (3Y Monthly) | 1.02 |
| PE Ratio (TTM) | 31.88 |
| EPS (TTM) | 0.0800 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Convatec Group Plc (LON:CTEC) Might Not Be A Great Investment
Today we are going to look at Convatec Group Plc (LON:CTEC) to see whether it might be an attractive investment...
- Simply Wall St.
What Convatec Group Plc's (LON:CTEC) ROE Can Tell Us
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
- Simply Wall St.
Need To Know: Convatec Group Plc (LON:CTEC) Insiders Have Been Buying Shares
It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be...
- Simply Wall St.
Should You Think About Buying Convatec Group Plc (LON:CTEC) Now?
Convatec Group Plc (LON:CTEC), which is in the medical equipment business, and is based in United Kingdom, received a...
- Reuters
UK Stocks-Factors to watch on May 3
(Adds company news items and futures) May 3 (Reuters) - Britain's FTSE 100 index is seen opening 1 point higher at 7,352 on Friday, according to financial bookmakers, while FTSE 100 futures were up 0.13 ...
- Reuters
European stocks claw back up after four-day drop
European shares rose on Tuesday, snapping a four-day losing streak, boosted by healthcare stocks and on indications that UK Prime Minister Theresa May's deal to exit the European Union could gain some support. The pan-region STOXX 600 index added to early gains and rose 0.8 percent, led by Switzerland and Paris's near 1 percent jump, followed by Frankfurt's 0.6 percent gain. Milan rose 0.4 percent, while London's FTSE closed 0.26 percent higher.
- Reuters
Medical device maker ConvaTec names Genus top boss as CEO
The company said outgoing Chief Executive Officer Rick Anderson will become executive chairman on a temporary basis from May 9 and will work with senior leadership until Bitar joins on Sept. 30. ConvaTec has been struggling to find its footing after being hit by logistical issues, recalls and a change in inventory policy by a leading customer, named by analysts as Medtronic. The company's former CEO Paul Moraviec, who guided ConvaTec through a $1.8 billion initial public offering in 2016, stepped down last October following warnings of lower sales and profitability, which had sent shares plummeting to a record low.
- Reuters
ConvaTec to appoint Karim Bitar from Genus as CEO - Sky News
(Reuters) - Catheter and colostomy bag maker ConvaTec Group Plc will on Monday appoint Karim Bitar as the company's chief executive officer, and will announce the departure of its Chairman Christopher ...
- Reuters
FTSE 100 squeezes out gains; ConvaTec drags midcaps
The FTSE 100 added 0.1 percent, outperforming its U.S. and European peers, though the FTSE 250 was down 0.4 percent as ConvaTec tanked after reporting what its CEO called "disappointing results". Investors also kept an eye on the ongoing parliamentary turmoil over Prime Minister Theresa May's Brexit plan. "The fact that there will now be another meaningful vote on Feb. 27 has taken the pressure off today's vote ... but Theresa May's 'my deal or no deal' doesn't look like it will make it into next month," London Capital Group analyst Jasper Lawler said.
- Reuters
ConvaTec's shares plummet on weak results, draws up turnaround plan
The company, whose chief executive left after a sales and profit warning in October, said it would focus on products and market segments that offer the best returns, develop a strong pipeline of new products and simplify its business. The company was just finding its footing after logistical issues and recalls that dented income last year, when a change in inventory policy by a leading customer, named by analysts as Medtronic, forced it to trim earnings outlook in October. Including the costs related to its transformation plan, Convatec forecast operating profit margin of 18-20 percent for fiscal 2019, lower than the 23.4 percent for 2018.
- CNBC
European markets rally amid earnings; China trade data beats expectations; Convatec shares tumble 18%
European stocks were higher on Thursday morning, as market participants monitored a flurry of earnings results.
